Aqr Capital Management LLC Reata Pharmaceuticals Inc Transaction History

Aqr Capital Management LLC

$71.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $18,379 - $24,445	-232 Reduced 3.75%	5,957 $607,000
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $190,930 - $576,629	6,189 New	6,189 $562,000
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $179,700 - $316,710	-8,677 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $209,289 - $343,609	8,677 New	8,677 $284,000
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $301,977 - $425,523	-3,204 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $72,747 - $131,634	-713 Reduced 18.2%	3,204 $393,000
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $1.07 Million - $1.87 Million	-11,475 Reduced 74.55%	3,917 $378,000
Q2 2020 Aug 17, 2020	SELL	$126.3 - $176.56 $38,521 - $53,850	-305 Reduced 1.94%	15,392 $2.4 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $697,779 - $1.39 Million	5,620 Added 55.77%	15,697 $2.27 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $69,424 - $202,883	-931 Reduced 8.46%	10,077 $2.06 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $24,157 - $32,459	-339 Reduced 2.99%	11,008 $884,000
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $566,423 - $687,622	-7,288 Reduced 39.11%	11,347 $1.07 Million
Q1 2019 May 14, 2019	SELL	$51.9 - $101.79 $17,542 - $34,405	-338 Reduced 1.78%	18,635 $1.59 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $697,804 - $1.09 Million	14,311 Added 306.97%	18,973 $1.06 Million
Q3 2018 Nov 15, 2018	SELL	$35.64 - $92.06 $102,179 - $263,936	-2,867 Reduced 38.08%	4,662 $381,000
Q2 2018 Aug 14, 2018	SELL	$19.94 - $40.96 $70,208 - $144,220	-3,521 Reduced 31.86%	7,529 $263,000
Q4 2017 Feb 14, 2018	SELL	$22.39 - $33.27 $53,444 - $79,415	-2,387 Reduced 17.76%	11,050 $313,000
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $353,258 - $428,371	13,437	13,437 $418,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account